Atibha Agriseeds Launches Open Offer to Buy 26% of Chemo Pharma at Rs.110 per Share

Atibha Agriseeds Private Limited has announced an open offer to acquire 26 per cent of Chemo Pharma Laboratories Limited's voting share capital at Rs. 110 per share. The tendering period will begin on May 22, 2025, and close on June 4, 2025, following the rules and regulations of the Securities and Exchange Board of India (SEBI) Takeover Code, 2011. This open offer is a voluntary acquisition attempt by Atibha Agriseeds, with the goal of acquiring a significant stake in Chemo Pharma.

Key Takeaways:

• Atibha Agriseeds Private Limited is planning to acquire 3,90,000 fully paid-up equity shares, which is 26 per cent of Chemo Pharma Laboratories Limited's voting share capital.
• The offer price is Rs. 110 per share, and the payment will be made in cash.
• The open offer follows the SEBI guidelines, including those mentioned in circulars issued in 2015, 2016, 2017, 2019, 2020, and 2021.
• The treaty is a voluntary open offer from Atibha Agriseeds with the objective of acquiring a substantial stake in Chemo Pharma.
• The Bombay Stock Exchange (BSE) has released a notice informing all trading members and custodians about the offer, and all details are available on the BSE website.

Statistics:

• The tendering period for the open offer will begin on May 22, 2025, and close on June 4, 2025.
• The open offer aims to acquire 26 per cent of Chemo Pharma Laboratories Limited's voting share capital.
• The offer price is Rs. 110 per share.

Sources:

• "Open Offer" by Atibha Agriseeds Private Limited, dated May 2025, as mentioned in the Bombay Stock Exchange (BSE) notice.
• "SEBI Takeover Code, 2011" circulars, dated 2015, 2016, 2017, 2019, 2020, and 2021.
• "Bombay Stock Exchange (BSE) notice" dated May 2025.